Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
552
-
Total 13F shares, excl. options
-
91,808,512
-
Shares change
-
-1,129,133
-
Total reported value, excl. options
-
$11,695,853,623
-
Value change
-
-$78,854,430
-
Put/Call ratio
-
108%
-
Number of buys
-
255
-
Number of sells
-
-212
-
Price
-
$127.38
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2014
605 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q4 2014.
Edwards Lifesciences Corp - Common Stock (EW) has 552 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91,808,512 shares
of 590,231,680 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (8,813,400 shares), VANGUARD GROUP INC (8,665,085 shares), Capital World Investors (5,439,400 shares), State Street Corp (4,938,236 shares), GENERATION INVESTMENT MANAGEMENT LLP (4,189,138 shares), FMR LLC (4,033,412 shares), WELLINGTON MANAGEMENT GROUP LLP (3,587,752 shares), BlackRock Institutional Trust Company, N.A. (3,019,490 shares), BlackRock Fund Advisors (1,758,789 shares), and NORTHERN TRUST CORP (1,427,802 shares).
This table shows the top 552 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.